Immunoglobulin Market Size

Immunoglobulin Market Size

Immunoglobulin Market size was valued at around USD 15.3 billion in 2022 and is estimated to reach USD 32.2 billion by 2032. The market is poised for accelerated growth due to the increasing adoption of both organic and inorganic strategies by various market players.

To get key market trends

  Download Free Sample

For instance, Takeda's recent announcement in April 2023, regarding the U.S. Food and Drug Administration's approval of a supplemental biologics license application (sBLA) to broaden the application of HYQVIA, a subcutaneous immune globulin (ScIG) used for treating primary immunodeficiency (PI) in children aged 2-16, serves as an illustrative example. This growing number of product approvals is expected to bolster market expansion. Additionally, the rising prevalence of autoimmune diseases like Guillain-Barre syndrome, primary immunodeficiency disease (PID), and immune thrombocytopenic purpura (ITP), among others, is set to further propel market progress.

Immunoglobulins, also known as antibodies, are specialized proteins produced by the immune system in response to the presence of foreign substances such as bacteria, viruses, and other pathogens. They play a critical role in the body’s defense against infection and diseases by recognizing and binding to specific antigen on the surface of this invaders, thereby making them for disruption by other immune cells or neutralizing their harmful effects. There are several types of immunoglobulins including IgA, IgD, IgE, IgG, and IgM each with unique structures and functions.